Adoptive cell transfer therapy with ex vivo primed peripheral lymphocytes in combination with chemotherapy in locally advanced or metastatic triple-negative breast cancer: the ImmunoBreast phase Ib clinical trial
Authors
Anne Marie Bak Jylling (ORCID: https://orcid.org/0000-0002-8071-549X)
Lars Johan Sandberg
Henrik J. Ditzel (ORCID: https://orcid.org/0000-0003-3927-5135)
A.P. Møller og Hustru Chastine Mc-Kinney Møllers Fond til almene Formaal
Fabrikant Einar Willumsens Mindelegat
Grosserer M. Brogaard og Hustrus Mindefond
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article
Adoptive cell transfer therapy with ex vivo primed peripheral lymphocytes in combination with chemotherapy in locally advanced or metastatic triple-negative breast cancer: the ImmunoBreast phase Ib clinical trial
Anne Marie Bak Jylling, Lars Johan Sandberg, Henrik J. Ditzel, Sidse Ehmsen et al.
Journal
Journal for ImmunoTherapy of Cancer
Topics
CAR-T cell therapy research
article
Adoptive cell transfer therapy with ex vivo primed peripheral lymphocytes in combination with chemotherapy in locally advanced or metastatic triple-negative breast cancer: the ImmunoBreast phase Ib clinical trial
Anne Marie Bak Jylling, Lars Johan Sandberg, Henrik J. Ditzel, Sidse Ehmsen, Odd Lilleng Gammelgaard, Annette Raskov Kodahl, Alexei F. Kirkin
article en
Abstract
No abstract available for this paper.
Publication Tag
Journal for ImmunoTherapy of CancerVol. 13(12)
Institutions
University of Southern Denmark (DK), Odense University Hospital (DK), Cytovac (Denmark) (DK)
Funders
Dagmar Marshalls Fond, A.P. Møller og Hustru Chastine Mc-Kinney Møllers Fond til almene Formaal, Fabrikant Einar Willumsens Mindelegat, Grosserer M. Brogaard og Hustrus Mindefond